Uploaded December 2025 | Updated September 2026, 1 week ago
For references and a written breakdown, see the associated newsletter: staycuriousmetabolism.substack.com/p/weve-been-prescribing-statins-wrong?r=40ekz2
For a consolidated resource on prior StayCurious Heart Health Content, check out our Heart Health Map! open.substack.com/pub/staycuriousmetabolism/p/the-intricate-metabolic-web-of-heart?r=40ekz2&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
Statins are among the most prescribed and profitable drugs in the world, but new research is forcing us to rethink what they actually do — and for whom. In this video, Dr. Nick Norwitz MD PhD breaks down the latest data showing that statins only reduce cardiovascular risk in people with existing heart disease, while showing little or no benefit for those without.
Nick walks through, not one, but 4 major studies and explains why LDL cholesterol and ApoB aren’t the whole story, how coronary imaging (CAC or CTA scans) provide better risk prediction, and why the real root causes — like insulin resistance and mitochondrial dysfunction — often get ignored. This isn’t about conspiracy or fear — it’s about context. Good medicine isn’t black or white — it’s nuanced, transparent, and collaborative.
Chapters
0:00 – Intro: Statins as a Misunderstood Tool
1:46 – Paper 1, Statins Don’t Benefit Those Without Heart Disease
3:43 – Imaging Beats LDL and ApoB for Risk Stratification
4:26 – Paper 2, If Your Heart is Clear, Does LDL Cholesterol Matter?
5:33 – Reviewing the Pros and Cons of Statins
6:43 – Paper 3, Statins Harm Mitochondria and Muscles
7:55 – Paper 4, Statins Slash GLP-1 Levels
9:00 – The Essential Social Dynamics of Statins You Need to Know
11:15 – Conclusion, The Right Tool for the Right Job
#Statins #HeartHealth #Cholesterol #LDL #ApoB #InsulinResistance #MetabolicHealth #Mitochondria #Type2Diabetes #CardiovascularHealth #Medicine #Pharmaceuticals #GLP1 #CoQ10 #StayCurious #NickNorwitz #Educational #ScienceCommunication #CriticalThinking #HealthResearch #StayCurious
For references and a written breakdown, see the associated newsletter: staycuriousmetabolism.substack.com/p/weve-been-prescribing-statins-wrong?r=40ekz2
For a consolidated resource on prior StayCurious Heart Health Content, check out our Heart Health Map! open.substack.com/pub/staycuriousmetabolism/p/the-intricate-metabolic-web-of-heart?r=40ekz2&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
Statins are among the most prescribed and profitable drugs in the world, but new research is forcing us to rethink what they actually do — and for whom. In this video, Dr. Nick Norwitz MD PhD breaks down the latest data showing that statins only reduce cardiovascular risk in people with existing heart disease, while showing little or no benefit for those without.
Nick walks through, not one, but 4 major studies and explains why LDL cholesterol and ApoB aren’t the whole story, how coronary imaging (CAC or CTA scans) provide better risk prediction, and why the real root causes — like insulin resistance and mitochondrial dysfunction — often get ignored. This isn’t about conspiracy or fear — it’s about context. Good medicine isn’t black or white — it’s nuanced, transparent, and collaborative.
Chapters
0:00 – Intro: Statins as a Misunderstood Tool
1:46 – Paper 1, Statins Don’t Benefit Those Without Heart Disease
3:43 – Imaging Beats LDL and ApoB for Risk Stratification
4:26 – Paper 2, If Your Heart is Clear, Does LDL Cholesterol Matter?
5:33 – Reviewing the Pros and Cons of Statins
6:43 – Paper 3, Statins Harm Mitochondria and Muscles
7:55 – Paper 4, Statins Slash GLP-1 Levels
9:00 – The Essential Social Dynamics of Statins You Need to Know
11:15 – Conclusion, The Right Tool for the Right Job
#Statins #HeartHealth #Cholesterol #LDL #ApoB #InsulinResistance #MetabolicHealth #Mitochondria #Type2Diabetes #CardiovascularHealth #Medicine #Pharmaceuticals #GLP1 #CoQ10 #StayCurious #NickNorwitz #Educational #ScienceCommunication #CriticalThinking #HealthResearch #StayCurious
